Drug Shortage Report for APO-RILUZOLE

Last updated on 2022-09-23 History
Report ID 103385
Drug Identification Number 02352583
Brand name APO-RILUZOLE
Common or Proper name RILUZOLE
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) RILUZOLE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60 BTL
ATC code N07XX
ATC description OTHER NERVOUS SYSTEM DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-13
Estimated end date 2022-09-23
Actual end date 2022-09-22
Shortage status Resolved
Updated date 2022-09-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2022-09-23 French Compare
v15 2022-09-23 English Compare
v14 2022-09-06 French Compare
v13 2022-09-06 English Compare
v12 2021-11-19 French Compare
v11 2021-11-19 English Compare
v10 2021-11-08 French Compare
v9 2021-11-08 English Compare
v8 2021-09-21 French Compare
v7 2021-09-21 English Compare
v6 2021-08-19 French Compare
v5 2021-08-19 English Compare
v4 2021-06-15 French Compare
v3 2021-06-15 English Compare
v2 2020-01-15 French Compare
v1 2020-01-15 English Compare

Showing 1 to 16 of 16